# Is India getting healthier? > Life expectancy climbed, child deaths fell, and more doctors are registered. But wasting persists, chronic diseases overtook infections, and out-of-pocket spending remains a heavy burden. **India's Health: Better, Mixed, and Worse** India’s survival gains are real: life expectancy hit about 70 years in 2021, under-five mortality fell sharply, and institutional delivery exceeds 88%. Infections are declining. But wasting affects one in five children, barely changed since 2015-16. Non-communicable diseases now dominate, accounting for over 60% of disease burden. Risk factors like high blood sugar, overweight, and air pollution are rising. Healthcare financing remains regressive: out-of-pocket expenditure still exceeded 50% of total health spending in 2019, and public facilities are thin. Access and outcomes vary hugely by wealth quintile and state. ## How much longer are Indians living now? Life expectancy at birth in India increased from 45.6 years in 1960 to 72.2 years in 2024, a gain of over 26 years. The world average rose from 50.9 years to 73.5 years over the same period, so India has narrowed the gap substantially. Yet India still lags several Asian neighbours: Bangladesh reached 74.9 years, Sri Lanka 77.7 years, and China 78.0 years, all in 2024. The improvement is driven largely by fewer child deaths and declining infectious disease mortality. Readers should note that these are period estimates based on current death rates and do not predict how long any one child will live. Minor differences between data sources, such as the World Bank and the WHO, are normal and do not change the overall pattern. ## Are those extra years spent in good health? While life expectancy at birth reached 72.2 years in 2024, the World Health Organization estimated a healthy life expectancy of only 58.2 years in 2021. That leaves a gap of roughly 14 years lived with some disease or disability. The healthy life expectancy figure itself has a plausible range from 57.6 to 58.9 years, reflecting inherent uncertainty. Because the life expectancy number comes from the World Bank and the healthy life expectancy from the WHO, the two may not align perfectly; the gap should be read as an approximation, not a precise difference. Still, the message holds: longer life does not automatically mean more years in full health. As chronic conditions increasingly replace infections, the goal shifts from simply keeping people alive to preserving their quality of life. ## How much have child deaths fallen in India? The sharpest driver of longer life has been the collapse in child mortality. In 1960, the under-5 mortality rate was 241.3 deaths per 1,000 live births, meaning almost one in four children did not survive to age five. By 2024, that rate had fallen to 26.6 per 1,000, a drop of nearly 90 per cent. India now outperforms the world average of 37.4 and the lower-middle-income average of 43.8, and it edges close to Bangladesh at 30.5. Vietnam and Indonesia, at 17.3 and 17.7 respectively, remain ahead. The figures are modelled from birth registrations and survey data, so they carry uncertainty, especially for the earliest years. Even so, the trend is unambiguous: expanded vaccination, better nutrition, and improved access to care have turned child survival into India’s most visible public-health achievement. ## How much has India's maternal mortality ratio fallen, and how does it compare to other countries? India's maternal mortality ratio fell from about 658 per 100,000 live births in 1985 to around 80 in 2023. This puts India below the 2023 global average of nearly 197 and the lower-middle-income average of 235. But the best Asian comparators are far lower: Sri Lanka reached 18 and China 16 in 2023. Bangladesh (115) and Vietnam (48) also outperformed India. India started worse than Pakistan (432) and Indonesia (474) in 1985, so the decline is significant. Keep in mind that these are modelled estimates; focus on the broad direction, not single-year wiggles. ## Are the classic infectious and newborn killers in retreat? Disease burden from neonatal disorders, respiratory infections and tuberculosis, and enteric infections has fallen sharply. Disability-adjusted life years (DALYs) from neonatal disorders dropped from roughly 88 million in 1990 to about 35 million in 2023. Respiratory infections and TB fell from around 77 million to 35 million. Enteric infections saw the steepest decline, from nearly 97 million DALYs in 1990 to about 18 million in 2023. Note that these are absolute GBD model estimates; because India's population has grown, the drop in total burden is even more striking, confirming a real decline. ## How did India's measles vaccination coverage change, and where does it stand now? Measles immunization coverage in India rose from just 1% of children aged 12-23 months in 1985 to 97% in 2024. This is well above the 2024 global average of 84.3% and the lower-middle-income average of 86.4%. Neighbouring countries also made big gains: Bangladesh reached 96%, Vietnam 98%, and Sri Lanka 99%. Pakistan lags at 86%, while China went from 78% in 1983 to 95% in 2024. Keep in mind that these administrative figures can differ from household survey estimates, so read them as broad trends. ## Is maternal care in India becoming more comprehensive? Yes, care around birth is becoming more comprehensive, but the picture includes a sharp rise in caesarean deliveries that warrants scrutiny. According to the National Family Health Survey, institutional births increased from 88.6% (2021) to 90.6% (2024). Births assisted by skilled health personnel rose from 89.4% to 91.3% over the same period. The share of mothers completing at least four antenatal visits climbed from 58.5% to 65.2%, and consumption of iron folic acid for 180 days or more rose from 26% to 37.8%. However, caesarean-section deliveries jumped from 21.5% to 27.2%. This rapid increase is not automatically alarming but requires careful monitoring, as it may signal overuse in some settings. These figures come from two survey rounds (NFHS-5 and NFHS-6) and are not annual data, so they represent broad shifts rather than precise yearly trends. ## Is India training far more doctors now? Yes, India has dramatically expanded its MBBS training pipeline. Data from the National Health Profile 2023 show that MBBS seats surged from 25,058 in 2007 to 1,04,163 in 2023, roughly a four-fold increase. This growth reflects the rise in medical colleges from 262 to 679 over the same period, a deliberate policy to build future healthcare capacity. However, these numbers represent training seats, not practising doctors. Many graduates choose to emigrate, specialise in non-clinical fields, or leave the profession. Therefore, the count of registered doctors on paper is far higher than the active clinical workforce that patients encounter. The expansion is a genuine investment, but the road from a classroom seat to a stethoscope in an underserved clinic remains long and uneven. These figures are administrative counts with reporting lags, so they should be seen as indicators of capacity, not real-time service availability. ## How does India’s child nutrition compare with its neighbours? Yes and no. Stunting among children under five has fallen markedly, from 62.7% in 1989 to 35.5% in 2020, but wasting has barely budged, moving from 20.3% in 1989 to 18.7% in 2020. Compared to regional peers, India still looks weak. Bangladesh reduced stunting from 70.9% (1986) to 23.6% (2022); Sri Lanka stands at 10.5% (2024); Vietnam at 18.2% (2023); Indonesia at 22% (2023); and China at just 4.8% (2017). Even Pakistan, with 37.6% stunting (2018), is closer to India’s level. The persistence of wasting at nearly one in five children signals that immediate nutrition, disease, and food quality remain stubborn challenges. These World Bank data come from survey-year observations, not smooth annual trend lines, and country years vary, so direct comparisons should be treated with caution. Still, the pattern is clear: long-run stunting relief, but India’s nutritional profile remains frail. ## Is child nutrition improving in India? The latest National Family Health Survey (NFHS-6, 2024) shows a mixed picture. Between the 2021 and 2024 rounds, stunting among children under five fell from 35.5% to 29.3%, a meaningful decline. However, wasting remained stubborn at around 19% (19.3% in 2021 to 19% in 2024), while severe wasting improved from 7.7% to 5.2%. Underweight prevalence barely moved, from 32.1% to 31.8%. Only 15.3% of children aged 6-23 months received an adequate diet in 2024, up from 11% in 2021, but this remains very low. These numbers suggest that long-term nutritional status (stunting) is improving, possibly driven by better maternal health and sanitation, but acute malnutrition persists. Readers should note that NFHS-6 did not measure anaemia, so it cannot provide current estimates for anaemia prevalence among children or women. ## Are India’s health indicators all trending positively? Between NFHS-5 (2021) and NFHS-6 (2024), health indicators moved in multiple directions. Vaccination coverage surged: the rotavirus vaccine rose from 36.4% to 85.4%, and the measles second dose increased from 58.6% to 71.8%. Health insurance coverage jumped from 41% to 60.2%. Maternal care improved: mothers consuming iron folic acid for at least 180 days climbed from 26% to 37.8%, and early breastfeeding within one hour rose from 41.8% to 50.1%. Yet not all changes were benign. Caesarean sections rose from 21.5% to 27.2%, a 5.7-point increase that may signal medical overuse. Meanwhile, child nutrition showed little progress: wasting barely budged from 19.3% to 19%, and adequate diet increased only from 11% to 15.3%. Stunting did fall from 35.5% to 29.3%, but the overall picture is one of uneven progress. A positive change in an indicator does not automatically mean improvement. Rising C-section rates, for instance, can indicate unnecessary procedures. ## Where is the double burden of malnutrition most visible? India’s states display a striking coexistence of adult overweight and child undernutrition. NFHS-6 data show that in one state, 47.9% of women are overweight or obese, yet 24.6% of children under five are stunted and 10.8% of women remain thin. In another state, 29.3% of women are overweight, while child stunting is 24.1% and thinness among women is 6.8%. A third state reports 19.6% overweight women, with 30.3% child stunting and 15.6% thin women. These numbers illustrate that high rates of overweight do not eliminate undernutrition; the two often coexist within the same population. For instance, a state with nearly half of women overweight still has a quarter of children stunted. The chart displays only the overweight side of the double burden per state, but the underlying data carry stunting and thinness as well. Policymakers must therefore address both overnutrition and undernutrition simultaneously, even within the same states. ## Is India's double burden of malnutrition shifting? Yes but in an uneven way. Child stunting fell from 35.5% in NFHS-5 (2021) to 29.3% in NFHS-6 (2024), a genuine improvement. Yet child wasting barely moved, from 19.3% to 19%, so acute undernutrition persists. Meanwhile, adult overweight rose sharply: from 24% to 30.7% among women and from 22.9% to 27.3% among men. Disturbingly, women's thinness (below-normal BMI) crept up from 18.7% to 19.7%, running against the expectation that undernutrition would decline uniformly. The two malnutritions exist together: undernutrition is not vanquished even as overnutrition accelerates. This double burden puts pressure on health systems designed for a single problem. The caveat is important: these are two survey points and the trends coexist; they do not suggest that undernutrition will automatically give way to overnutrition. National averages also hide large gaps by wealth and state. ## How much does wealth still shape child health in India? A great deal. NFHS-5 data from 2021 show large gaps between the poorest and richest children across multiple health and access measures. For one indicator the gap was 23.2 percentage points, with state ranges from 22.9 to 46.1. Another measure recorded a 6.3-point gap, but the spread from 16.2 to 22.5 across states shows that even smaller averages obscure deep local divides. A third indicator had a gap of 29.4 percentage points, varying from 8.1 to 37.5. The poorest children consistently face much higher risk whether in nutrition, survival, or care. These figures confirm that wealth remains a stubborn driver of health inequity. The caveat: the numbers come from a 2021 survey; they are not a real-time 2026 inequality reading, and the precise indicators behind each gap are distinct. Still, the pattern is clear: economic disadvantage translates directly into worse health outcomes for children. ## Why does a national health average hide state-level diversity? Because India's states inhabit different epidemiological eras. NFHS-6 reveals that the distance between the highest and lowest state or union territory on a single health indicator can be enormous. One measure showed a spread of 20.5 percentage points, with state values ranging from a low of 16.6 to a high of 37.1. Another had a 16.1-point spread, extremes being 8.1 and 24.2. A third indicator varied by 30.1 points, from 11.2 to 41.3, and a fourth by 25.2 points, from 7.8 to 33.0. Such wide spreads mean that a national average can suggest a false uniformity. A policy designed for the mean will miss the extremes. This is especially true for maternal and child health indicators where progress has been uneven. The caveat: these are spreads from a survey, not a ranking, and estimates for small states and union territories can be noisy. Manipur is not included in the current NFHS-6 data set. So while the national story may be one of steady improvement, the state stories vary dramatically. ## Do rural and urban India have different health problems? Data from NFHS-6 reveal notable rural-urban differences in health indicators. For some measures, the gap reaches over 17 percentage points, while for others it is as narrow as 7 points. For instance, one indicator shows a 17.7 percentage-point difference, with urban areas recording 40.5% and rural areas 22.8%. In another case, the gap is 7 points but rural prevalence (30.9%) exceeds urban (23.9%), showing that higher is not always better. These absolute gaps obscure whether the condition is more common in rural or urban settings. A 14.4-point gap (rural 61.4%, urban 75.8%) and a 15.5-point gap (rural 33.7%, urban 49.2%) also illustrate this mix. Caveat: without knowing the specific indicators, it is easy to misread a gap as rural deprivation; the higher value could signal a health problem in urban areas, or a desirable outcome like treatment coverage. The numbers are from a household survey with sampling error, so small differences may not be meaningful. ## How has India's cause of death pattern changed since 1990? By 2023, non-communicable diseases (NCDs) accounted for 62.2% of India's total disease burden, up from 26.4% in 1990. Meanwhile, communicable, maternal, neonatal, and nutritional conditions fell from 65.6% to 26.6%. Injuries rose from 7.9% to 11.2%. This crossover, where NCDs overtook infections, happened around 2010. The change reflects improved control of infections and maternal issues, alongside rising lifestyle-related conditions. Caveat: these are modelled estimates from the Global Burden of Disease study, not direct measurements. Shares sum to 100%, but total burden also grew, so the rise in NCD share does not mean communicable diseases disappeared; absolute numbers may remain high. The shift means India's health system now has to manage both old and new challenges simultaneously. ## How does India's NCD burden compare with other countries? India's non-communicable disease burden as a share of total DALYs reached 62.2% in 2023, up from 26.4% in 1990. Among comparator economies, India's 2023 share is the lowest: other countries range from 68.7% to 82.1%. In 1990, India's share (26.4%) sat between a low of 22% and a high of 57.9%. While richer and older countries flipped earlier, India's transition occurred at a lower income level. For instance, one comparator had an NCD share of 82.1% in 2023, implying a health profile dominated by chronic diseases. India's relatively lower share does not signal better health; it reflects a continuing battle with infectious and nutritional conditions alongside rising NCDs. The rapid shift demands policy attention. Caveat: All figures are modelled GBD estimates, not exact counts. The comparison uses a selected set of economies; a different set would produce a different picture. ## What diseases dominate India's health loss today compared to 1990? The Global Burden of Disease study shows a dramatic shift in India’s health loss between 1990 and 2023. Cardiovascular diseases have become the largest contributor, with DALYs doubling from 41 million to 80 million. Cancers, diabetes and kidney diseases, and mental and musculoskeletal disorders all roughly doubled or more in absolute burden. In contrast, the burden from infections and neonatal disorders collapsed: enteric infections dropped from 97 million DALYs to 18 million, neonatal disorders from 88 million to 35 million, and respiratory infections and TB from 77 million to 35 million. These modelled estimates capture a national-scale reordering, though absolute numbers are lifted by population growth and should not be read as precise community-level counts. ## Which causes actually kill the most Indians? In raw counts, one cause dwarfs the rest. IHME’s GBD model estimates that cardiovascular disease killed about 3.1 million Indians in 2023, roughly as many as the next three causes put together: chronic respiratory disease (around 1.25 million), cancers (about 1.06 million) and diabetes (close to 0.6 million). The classic infectious and newborn killers that once topped this list now sit well below it, with diarrhoeal disease near 0.46 million, lower respiratory infections around 0.41 million, tuberculosis about 0.33 million and newborn disorders close to 0.30 million. These are modelled estimates, not a death register, and they are counts rather than rates, so a larger and older population pushes every total upward. India’s own SRS survey, built from an entirely different method, agrees on the headline: heart disease leads by a wide margin. Read alongside the burden chart, the contrast is the point. By lives lost, heart disease dominates; by years of healthy life lost, childhood causes still weigh more because they strike so early. ## Do men and women in India die of different things? India’s own death registration shows men and women dying of visibly different things. In the Registrar General’s Causes of Death data for 2017 to 2019, cardiovascular disease accounted for 30.8% of male deaths but 26.2% of female deaths, and road accidents for 5.2% of male deaths against just 1.4% of female ones, so men die far more often on the roads. Cancers took a slightly larger share of women’s deaths (7.3% versus 6.4%). The starker gap is in what goes unrecorded: ill-defined causes made up 15.5% of female deaths but 9.7% of male deaths, and fever of unknown origin 6.0% versus 4.2%. Nearly one in six women’s deaths had no clear cause assigned, against roughly one in ten men’s. That is not a disease pattern; it is an access and recording gap, because women’s deaths are less likely to reach a doctor or a diagnosis. These are shares of each sex’s own deaths, pooled over three years, and they predate the 2023 counts above. ## Are India’s death records getting better? The recording gap is not only a women’s problem; it is a whole-system one. The share of registered deaths carrying a doctor-certified cause rose from 14.2% in 1995 to 22.5% in 2020, real progress, but it means that even now only about one in five registered deaths has a medically certified cause, and registration itself still misses many deaths. Medical certification leans heavily on urban hospitals, so it says little about how rural India dies. This is exactly why the cause-of-death picture in this article rests on the SRS verbal-autopsy survey and on the GBD model rather than on death certificates: the certificates simply do not exist for most Indians. The slow climb is the good news; the low ceiling is the catch. Better records would let India see its own health directly, instead of having to infer it. ## Are more Indians dying by accident or suicide? Two external causes of death move in different directions. Police-recorded accidental deaths stayed roughly flat across the decade, near 4 lakh a year, dipping to 3.74 lakh in 2020 when the lockdown emptied the roads, then rebounding. Suicides did not plateau. They rose from about 1.36 lakh in 2011 to 1.64 lakh in 2021, a rise of roughly a fifth, and it was almost entirely among men, whose recorded suicides jumped from 87,839 to 118,979 while women’s stayed near 45,000. The sharpest climb came in the COVID years, 2019 to 2021. These are police figures, and suicide is widely under-reported, so treat them as a floor. They are counts, not rates, so part of the rise reflects a growing population. Even so, the direction is clear, and it sits on the worse side of the ledger: as India beats back infection, mental distress and self-harm are claiming more of its young. ## Are Indian adults getting heavier and more diabetic? Between the two most recent rounds of the National Family Health Survey, metabolic risk factors edged higher for Indian adults. Overweight or obesity prevalence among women aged 15-49 rose from 24% (NFHS-5, period ending 2021) to 30.7% (NFHS-6, reference March 2024), and among men from 22.9% to 27.3%. High or very high blood sugar (or medication use) among those 15 and older climbed from 13.5% to 17.8% for women and from 15.6% to 20.9% for men. Elevated blood pressure showed a slight decline or stability: women dropped from 21.3% to 19.4%, men from 24% to 22.1%. These are field measurements from two survey points; they describe household-level trends but cannot establish causation. ## How does India's diabetes prevalence compare to other countries? India’s adult diabetes prevalence has risen sharply, according to modelled estimates from the International Diabetes Federation. In 2024, India’s prevalence among people aged 20-79 stood at 10.5%, up from 9% in 2011. Among comparator economies, some face even higher burdens: one recorded 13.2% in 2024, up from 10.5% in 2011; another 11.9%, up from 8.8%; while a few economies remained lower, around 3-4%, up modestly from similar levels in 2011. These model-based figures rely on limited data points per country and should be seen as broad-brush comparisons, not precise survey counts. They show that India is part of a global rise in diabetes, with rates approaching or exceeding those of many middle- and high-income peers. ## How large is the silent disability from mental and musculoskeletal disorders? Mental disorders accounted for about 30 million disability-adjusted life years (DALYs) in India in 2023, up from roughly 12 million in 1990. Musculoskeletal conditions, such as back pain and arthritis, imposed another 27 million DALYs in 2023, also up from about 12 million in 1990. These numbers reflect years lived with disability, not deaths, and capture conditions that often go unreported. The actual burden is likely higher because mental and musculoskeletal disorders are under-diagnosed and under-recorded in health data. While life expectancy has risen, a growing share of India's ill-health now comes from disorders that persist silently, affecting daily function but rarely leading to death. This shift demands attention even though these conditions do not show up in mortality statistics. ## Which risk factors are responsible for the most deaths in India now? Air pollution was the single largest risk factor, attributed to around 2 million deaths in 2023. High systolic blood pressure followed, contributing to roughly 1.6 million deaths. High fasting plasma glucose was linked to about 970,000 deaths, and smoking to about 740,000 deaths. Since people are often exposed to multiple risks, these estimates cannot be added together. The figures come from modelled estimates of risk-attributable deaths in the Global Burden of Disease study, representing patterns rather than precise counts. Note how metabolic risks like high blood pressure and glucose have risen sharply since 1990, while deaths from unsafe water have fallen from about 1.1 million to about 310,000. The overall picture shows a transition from traditional environmental risks toward metabolic and lifestyle factors. ## How common are tobacco and alcohol use? Two of the biggest behavioural drivers of cancer and heart disease remain heavily male. In NFHS-6 (2023-24), 36.3% of men aged 15 and over used some form of tobacco and 18.9% drank alcohol, against 8.4% and 1.1% of women. The good news is small but real: men's tobacco use edged down from 38.0% in NFHS-5, and women's from 8.9%. The bad news is the level. More than one in three men still uses tobacco, which feeds directly into the rising cancer and cardiovascular burden seen elsewhere in this article. These figures are self-reported, so they almost certainly undercount real use, especially among women, where social stigma suppresses disclosure. The gender gap here is one of the widest in the whole survey, and it means India's tobacco-and-alcohol disease burden is overwhelmingly a male one, even as the household consequences fall on everyone. ## How much does household air pollution contribute to total pollution deaths? In 2023, about 2 million deaths in India were attributed to air pollution overall, up from around 1.3 million in 1990. Of these, household air pollution from solid fuels caused roughly 940,000 deaths in 2023, a drop from about 1.04 million in 1990. This decline reflects cleaner cooking fuels, yet household smoke still accounts for nearly half of all pollution-linked deaths. The estimates are modelled, not counted, and household pollution deaths are a subset of the total, so they do not add separately. Outdoor and indoor sources often combine in the same person’s exposure, making the burden difficult to disentangle. The trend shows a dual challenge: outdoor air pollution has likely risen, offsetting gains from reduced indoor smoke, so total deaths have increased even as household pollution has fallen. ## Who is paying for Indian healthcare now? The out-of-pocket share of total health spending fell from 64.2% in 2013-14 (year ending March 2014) to 43.4% in 2022-23 (year ending March 2023). Over the same period, the government’s share rose from 28.6% to 43.7%. This shift means that public spending now matches what households pay directly. However, these are shares, not absolute amounts; total government health expenditure remains about 1.4% of GDP. So while the relative burden on families has eased, many still face high costs, especially if they use private care. A cautious reading: the out-of-pocket share has fallen sharply, but given India’s low public health spending, even a larger share of a small pie may not be enough to fully protect households from catastrophic expenses. ## How much more does a private hospital stay cost than a government one? In 2025, the average spend per hospitalisation in a government hospital was 6,937 rupees, up only slightly from 6,120 rupees in 2014 (in current prices). In contrast, the average bill at a private hospital surged from 25,850 rupees to 56,215 rupees over the same period. This means a private stay costs over eight times as much as a public one. Caution: all figures are in current rupees, not adjusted for inflation, so part of the rise reflects price changes rather than a real increase in the volume of care. Also, the 2014 private figure includes total expenditure per case, not just medical costs, which makes the long-ago comparison a bit less precise. Even so, the difference is stark and shows why a hospital episode can be financially devastating for families without insurance, especially if they seek private care. The public system remains affordable but severely underutilised relative to the disease burden. ## Are private hospitals now the default for most Indians? In 2025, 57.9% of rural hospitalisations and 64.6% of urban hospitalisations took place in private facilities. These shares have barely budged since the mid-1990s, when 56.2% of rural and 56.9% of urban cases were treated privately. In other words, the private sector has long been the dominant provider, and its hold has even tightened slightly in cities. Caveat: these figures come from Indica’s own tabulation of NSS unit data for the 2025 round; the official MoSPI report may differ. Also, they count hospitalisation cases, not episodes of illness, so they miss the many who do not seek care at all. Still, the pattern is robust: even with the expansion of public insurance schemes, most Indians continue to turn to private hospitals when seriously ill, and they pay heavily for it, as the cost data showed. This reliance shapes both household budgets and the broader health financing challenge. ## How has health insurance coverage changed in recent years? Health insurance coverage in India has expanded dramatically. Among rural persons, the share with any health financing scheme jumped from 14.1% in mid 2018 to 47.4% by end 2025. In urban areas, coverage rose from 19.1% to 44.3% over the same period. Rural coverage roughly tripled, while urban coverage more than doubled. The gap between rural and urban has also reversed: earlier, urban areas had higher coverage, but by 2025, rural coverage slightly exceeded urban. A large part of this expansion is attributed to schemes like PMJAY. However, these numbers come from National Sample Survey data and measure persons covered, not households. They should not be compared directly with household level coverage estimates from NFHS, which use a different unit of measurement. So while the trend is clear, the exact levels differ across surveys. ## How do Indian families finance hospitalisation expenses? When hospitalisation occurs, Indian households still lean overwhelmingly on their own savings. According to a recent tabulation of NSS microdata, 76.7% of hospitalisation cases are financed mainly from income or savings. Borrowing accounts for 15% of cases, making it the second most common source. Support from friends and relatives covers 5.4% of cases, while sale of assets is rare, at just 0.6%. Another 1.5% is met through other means. This dependence on savings and debt shows the financial vulnerability that persists despite expanding health insurance. Importantly, this analysis excludes childbirth related hospitalisations and is based on Indica's own processing of public microdata; it may not fully represent the entire inpatient care landscape. Nonetheless, the finding that nearly four in five cases rely on own savings highlights why out of pocket health spending remains a major concern. ## Why do patients choose private over government hospitals? A key reason many families bypass free government facilities is concern over quality. In a self-reported survey, 29.7% of patients who chose a non government hospital said they did so because of poor quality in public institutions. Another 13% pointed to unavailability of a government facility. A preference for a trusted doctor drove 12.5% of private choices. Long waiting time, often assumed to be a major hurdle, was cited by only 4.2% of respondents. Other reasons, not specified, accounted for 36% of responses. These figures are based on Indica's tabulation and reflect patients' own stated reasons; they are not mutually exclusive, meaning a single patient could have multiple grievances. So while quality and access remain dominant complaints, the large share of 'other' hints at a variety of personal and practical considerations that push patients toward private care. ## Is India spending enough on health compared to other countries? India's current health expenditure was 3.3% of GDP in 2023, down from 4.1% in 2000. This is far below the world average of 10%. Among peers, China spends 5.9%, Vietnam 4.6%, and Sri Lanka 3.7%. India's share is lower than Nigeria's 4.2% and only slightly above Bangladesh's 2.2% and Indonesia's 2.7%. However, these figures include private out-of-pocket spending; public health spending alone is much smaller. The decline over two decades suggests that health spending has not kept pace with economic growth. This low investment limits access and quality, especially for the poor. Caveat: these totals include private out-of-pocket spending; public spending is even lower. ## Does India have enough doctors and hospital beds per person? India had 0.72 physicians per 1,000 people in 2020, unchanged since 2014, and 1.59 hospital beds per 1,000 in 2021, down from 2.13 in 2000. The world averages are 1.86 physicians and 3.29 beds. India's physician density is less than half the world figure, and bed density has fallen while the world's rose. These registered numbers may overstate availability as they include inactive or retired professionals and beds in non-functional facilities. The data gaps and different vintages across countries further complicate comparisons, but the shortfall is clear. With a growing population and rising chronic disease, the demand for healthcare workers and beds will only increase. Caveat: World Bank series have gaps; beds and doctors are reported in different vintages. ## What does childbirth cost in public and private hospitals? According to NSS data tabulated by Indica, the average medical expense for a delivery is Rs 2,359 in public hospitals, where 63.8% of deliveries occur and the C-section rate is 19.1%. In private facilities that handle 35.2% of births, the average cost rises to Rs 40,452 with a C-section rate of 61.5%. A small share of deliveries (1%) at charitable or trust hospitals cost Rs 20,550 with a 47.5% C-section rate. Thus, private care may cost over 17 times more than public, and C-section rates are markedly higher. These out-of-pocket expenses can be catastrophic for many families. The figures are current rupees from Indica's tabulation; the official report may differ. Caveat: Current rupees; Indica tabulation, official report may differ. ## Why are so many births now surgical? India's overall caesarean rate climbed from 21.5% of births in NFHS-5 to 27.2% in NFHS-6, but the average hides the real story. Split by where the birth happens, the gap is stark: by NFHS-6, 54.1% of births in private facilities were by caesarean, against 16.9% in public ones, a roughly threefold difference. Some of the rise is genuine, as mothers grow older and more first births are managed cautiously. But a private rate above half, three times the public one, is hard to explain on medical grounds alone and points to financial incentives, since a surgical delivery bills for far more than a normal one. The World Health Organization holds that a population caesarean rate above 10 to 15% is rarely justified by need. Read alongside the cost chart, this is the clearest sign that India's growing reliance on private hospitals brings more procedures, not only more access. ## How extensive is India's public health facility network? India's own count from the National Health Profile 2023 shows 1,61,829 sub-centres, 31,053 primary health centres, 6,064 community health centres, 1,275 sub-divisional hospitals and 767 district hospitals. These figures reflect a designed three-tier rural public system, progressing from village-level outreach to district inpatient care. However, the facility counts carry a reporting lag and say nothing about whether each is adequately staffed or supplied. ## What is the size of India's registered health workforce? The National Health Profile 2023 records 2.56 million registered nurses and midwives, 1.35 million registered allopathic doctors, and additional cadres of 1.71 million, 1 million and 2,94,102 registered professionals. These are cumulative registrations, not active or in-position staff; many individuals have retired, emigrated or left clinical work, and the figures thus overstate the working workforce substantially. ## Where are India's doctors concentrated? India's registered MBBS doctors are heavily clustered. Out of about 1.35 million, the top four states account for 2,11,046, 1,49,397, 1,34,448 and 1,05,804 doctors, while the next six range from 99,734 down to 49,047. This means a handful of states hold a disproportionate share of the national doctor count on paper. A critical caveat: these are registration records, not active practitioners, and doctors registered in one state may practise elsewhere, so the numbers reflect paper location rather than where care is actually delivered. ## What does a month of GLP-1 therapy cost in India? The monthly cost of GLP-1 drugs in India spans a wide range. One major brand costs around ₹25,148 (range ₹24,280-₹26,015). Another comes in at about ₹19,453 (₹13,125-₹25,781). A third option is priced near ₹11,030 (₹5,660-₹16,400). The most affordable generic is roughly ₹9,988 (₹8,800-₹11,175). These are reported retail prices, not regulated MRPs, and generic prices were still falling at the time of reporting. Even the cheapest GLP-1 remains far more expensive than metformin, a standard first-line diabetes drug. The sharp drop follows the March 2026 expiry of India’s core semaglutide patent, after which over 40 firms launched generics at around 90% below branded costs. Demand is surging: GLP-1 sales grew roughly 178% year-on-year in early 2026, and the market is projected to exceed half a billion dollars by 2030 against a backdrop of approximately 101 million Indians with diabetes. Any population-level impact from widespread use is speculative, not a measured outcome. Weight typically returns after stopping the drug, making this chronic therapy, and lean-muscle loss remains a concern, especially given India’s thin-fat phenotype, which may not align with Western trial results. ## How to read these numbers Five data systems underpin the article, each doing a different job. The Global Burden of Disease study (GBD 2023) models disease burden, causes and risk-attributed deaths. The National Family Health Survey (NFHS-5, 2019-21, and NFHS-6, 2023-24) measures prevalence through household interviews. The National Health Accounts (NHA) track who pays for care. The NSS 80th-round (2025) unit data, tabulated by Indica, captures household expenditure and service use; the official MoSPI report may differ. The World Bank harmonises and models for cross-country comparisons. The National Health Profile (NHP 2023) is India’s own count of facilities and registered workforce. "Latest available" seldom means "measured this year." NFHS-6 fieldwork ran 2023-24 but excluded Manipur and dropped anaemia testing, so under-5 haemoglobin estimates are unavailable. GBD outputs are modelled, not direct measurements. World Bank nutrition indicators use varying survey years. Health-spending denominators differ between NHA (current health expenditure per capita) and out-of-pocket shares. NHP registration counts are cumulative and on-paper: they are not counts of active, in-position staff. Facility numbers carry a reporting lag. NSS "persons covered" by health insurance refers to individuals, while NFHS "households covered" refers to households; the two denominators are not comparable. Wealth-quintile breakdowns reflect the survey year, not the present. The GLP-1 coda is speculative: list prices and patent facts are verified, but any population-level impact is a scenario, not a measured outcome. These data reveal patterns, not causes. ## Sources - Life expectancy, mortality, and health expenditure shares from World Bank HNP database, last accessed 2025. - Wealth quintile and state-level disparities, child nutrition indicators from NFHS-5 (2015-16) and NFHS-6 (2019-21). - Disease burden, cause-of-death, and risk factor estimates from IHME Global Burden of Disease Study 2023. - Healthcare financing shares and out-of-pocket expenditure from National Health Accounts, Ministry of Health and Family Welfare, 2019. - Household expenditure on healthcare, utilisation, and insurance coverage tabulated by Indica from NSS 80th-round unit data (2025). - Facility and workforce counts from National Health Profile 2023, Central Bureau of Health Intelligence (CBHI), Ministry of Health and Family Welfare. - Cross-country comparisons and healthcare system rankings from World Bank and WHO Global Health Expenditure Database. - Patent and pricing information for semaglutide (Ozempic) from public regulatory filings and news sources as of 2025. - Scenario modelling for GLP-1 impact uses published prevalence data and hypothetical adoption rates, not real-world tracking. - Office of the Registrar General & Census Commissioner, India, Causes of Death Statistics 2017-2019, as reproduced in the National Health Profile 2023 (CBHI): the sex split of India’s leading causes of death. - National Crime Records Bureau, Accidental Deaths & Suicides in India (ADSI), 2011-2021, as reproduced in the National Health Profile 2023: the count of accidental and suicide deaths. - Office of the Registrar General, India, Civil Registration System and Medical Certification of Cause of Death, via the National Health Profile 2023: the share of deaths with a certified cause. --- Source: [This Indian Life](https://thisindianlife.today/articles/is-india-getting-healthier/) · Updated 2026-06-17. Licensed CC BY 4.0. Please cite as "This Indian Life — https://thisindianlife.today".